Marcio Magalhães’ Post

🚀 𝐋𝐞𝐯𝐞𝐫𝐚𝐠𝐢𝐧𝐠 𝐀𝐈 𝐢𝐧 𝐏𝐡𝐚𝐫𝐦𝐚𝐜𝐞𝐮𝐭𝐢𝐜𝐚𝐥𝐬: 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐟𝐫𝐨𝐦 𝐒𝐚𝐧𝐨𝐟𝐢'𝐬 𝐃𝐢𝐠𝐢𝐭𝐚𝐥 𝐓𝐫𝐚𝐧𝐬𝐟𝐨𝐫𝐦𝐚𝐭𝐢𝐨𝐧 🚀 In an enlightening conversation at the 42nd annual JP Morgan Healthcare Conference, Emmanuel Frenehard, Sanofi's Chief Digital Officer, unveiled the pharmaceutical giant's ambitious AI strategy, underscoring a future where AI empowers innovation, efficiency, and patient care. Sanofi categorizes AI into three distinct types: - 𝐒𝐩𝐞𝐜𝐢𝐚𝐥𝐢𝐳𝐞𝐝 𝐀𝐈, critical for research and innovation, creating a unique space for intellectual property. 🔬 - 𝐒𝐧𝐚𝐜𝐤𝐚𝐛𝐥𝐞 𝐀𝐈, democratizing AI's power across the company, enhancing everyday decision-making. 📲 - 𝐆𝐞𝐧𝐞𝐫𝐚𝐭𝐢𝐯𝐞 𝐀𝐈, a new frontier exploring creative and regulatory document generation, promising to revolutionize patient care and operational efficiency. 🎨 Despite being in the early stages of leveraging generative AI, Sanofi envisions its impact across manufacturing, clinical studies, employee productivity, and content creation. This is a testament to AI's potential in not only streamlining processes but also in enhancing the creativity and efficiency of solutions provided to healthcare professionals and patients. Frenehard also highlighted the importance of responsible AI—a framework ensuring AI's reliability, fairness, and eco-friendliness. This approach underscores the need for AI technologies to be transparent, accountable, and secure, aligning with ethical standards crucial for patient care and environmental sustainability. 🌍 The conversation also touched upon the challenges, including the risk of "hallucinations" or inaccuracies in AI-generated content, emphasizing the importance of human oversight and continuous validation to ensure clinical soundness. As AI technologies evolve, the potential to dramatically shorten the distance between patients and treatments, particularly for rare diseases, becomes increasingly tangible. Generative AI, despite its nascent stage in healthcare, holds promise for early diagnosis, symptom detection, and ultimately, better patient outcomes. As we stand on the brink of this transformative era, it is clear that AI will play a crucial role in shaping the future of healthcare, driving both operational excellence and improved patient care. https://lnkd.in/d4ZJ5NEz #HealthcareInnovation #DigitalTransformation #ArtificialIntelligence #Pharmaceuticals #PatientCare #Sanofi

Join us for the #2024GlobalSummit this week! Enable innovation in your organization through Modularized AI solutions. Join Sudarshan KL at PMSA summit 2024 to learn more RWE is rapidly becoming a crucial tool for understanding real-world drug effectiveness, informing healthcare decisions, and ultimately improving patient outcomes. However, the evolving landscape of AI changes the dynamics of how we treat and utilize RWE data. Join us to discuss: 1. Key challenges in implementing RWE and cost-effective RWD integration. 2. Utilizing RWE beyond traditional use cases. 3. XAI (Explainable AI) - How to model explainability into your enterprise analytics. 4. Unlocking the potential of RWE today with impactful approaches. Learn more and register: https://lnkd.in/esAUPv7W #2024GlobalSummit #PMSASummit #RWE #RWD #RealWorldData #RealWorldEvidence #HealthcareAnalytics #AIinHealthcare #HealthcareIT #DigitalHealth #PublicHealth #PrecisionMedicine #DataScience #ClinicalTrials #PatientOutcomes #HealthcareInnovation

Don't miss out on the AI-focused sessions at MM+M Transform in NYC on Wednesday, April 3rd, where cutting-edge discussions on artificial intelligence will take center stage with a dedicated AI block. "All signal and no static: AI is not coming to replace you" with Ramon Soto and Ryan Younger from Northwell Health and Virtua Health. Dive into "The dos and don’ts of AI in health marketing" with experts from RevHealth, DeepIntent, and Ferring Pharmaceuticals. Discover "AI and your brand marketing team: new roles, new structure" featuring speakers from Lithero, Sound Healthcare Communications, and AbbVie. Discover how conversational AI revolutionizes pharmaceutical marketing, optimizing customer engagement, driving conversions and leveraging real-time insights to enhance future campaigns, presented by Matt Titus, General manager of Conversational AI for Swoop Register today! https://lnkd.in/e8petkmf #MMMTransform #Providerengagement #payengagement #medicalmarketing #healthtechinnocation #healthcaretechnology #patientengagment #healthcaretrends

With AI being the talk of the future, I am excited to see what efficiencies AI will drive in Clinical Trials.

Join us for the #2024GlobalSummit this week! Excited to announce that Sudarshan KL, will be presenting on "RWE Analytics & RWD Integration, Modularized with AI" at the 2024 Global Summit this Friday, March 8th at 2:45 PM IST! RWE is rapidly becoming a crucial tool for understanding real-world drug effectiveness, informing healthcare decisions, and ultimately improving patient outcomes. However, the evolving landscape of AI changes the dynamics of how we treat and utilize RWE data. Join us to discuss: 1. Key challenges in implementing RWE and cost-effective RWD integration. 2. Utilizing RWE beyond traditional use cases. 3. XAI (Explainable AI) - How to model explainability into your enterprise analytics. 4. Unlocking the potential of RWE today with impactful approaches. Learn more and register: https://lnkd.in/esAUPv7W #2024GlobalSummit #PMSASummit #RWE #RWD #RealWorldData #RealWorldEvidence #HealthcareAnalytics #AIinHealthcare #HealthcareIT #DigitalHealth #PublicHealth #PrecisionMedicine #DataScience #ClinicalTrials #PatientOutcomes #HealthcareInnovation

Don't forget to secure your spot for "Can AI reveal real-time insights?" happening live on May 8: https://lnkd.in/g8uktUsQ Join me for an insightful discussion hosted by Reuters where industry leaders from GSK, AstraZeneca, and Novartis, alongside Within3 CEO, Lance Hill, will be uncovering the transformative power of #AI when applied to market behavior analysis and HCP #insights.

One of the reasons I decided to join Sanofi was the declarative investment that Sanofi had made on AI. One of our strategic imperatives is "All in on AI" which enabled me to hit the ground running from Day 1. I didn't have to come in and convince our leaders to invest in it. AI won't be a choice, it will just be a way of life for all of us and for that we all need to choose to embrace AI and decide what it means for us. In your career if you don't choose to embrace AI in your own way, you won't be competing with AI for your job, you will be competing against the person next to you, who chose to embrace AI. You got this! #AIisourfuture #artficialintelligence #futureproofyourself

We recently released: "What It Takes to Lead Across the Health Ecosystem - Top Industry Trends & Solutions for Developing Leaders Today." Today, we highlight Trend #1: A New AI Frontier - and we're sharing a page straight from the report. AI is revolutionizing healthcare—answering medication queries, scheduling appointments, diagnosing conditions, and analyzing data swiftly. Generative AI goes further, helping health systems and pharmaceutical companies enhance patient care and outcomes. Leaders must adopt and integrate AI into their processes. McKinsey & Company notes that unlocking AI’s value is a leadership challenge, requiring senior executives to drive adoption, attract talent, and manage change effectively. Download the report for every page, and to learn more about this trend and our actionable solutions. 🔗 https://bit.ly/4e7tzdd #AI #GenerativeAI #HealthcareInnovation

🚨 Exciting Panel Discussion Alert! 🚨 Join us at the AI in Healthcare & Pharma Summit in Boston on Nov 13-14 at The Colonnade Hotel for an insightful panel: "Addressing Bias and Promoting Fairness with Equitable AI in Healthcare and Pharma." 🌟 Key topics include: 🔹 Strategies to identify and mitigate biases in AI systems 🔹 Developing frameworks to ensure equitable healthcare and fair clinical trials 🔹 Importance of diverse datasets in AI model training 🔹 Addressing ethical considerations in AI development and deployment 🎤 Speakers: - Anemone Kasasbeh, Lead Data Scientist, United Health Services - Todd Bresler, Associate Director, IBD Patient Services Digital Operations, Takeda - Kausar Riaz Ahmed, PhD, MBA, RAC, Director, Generative AI Medical Engagement Lead, Pfizer 📅 Don’t miss out! Learn how AI can drive fairness and equity in healthcare and pharma. https://hubs.ly/Q02S8QYb0 #reworkAI

🚀 Exciting News Alert! 🚀 Revolutionizing Clinical Trials, Empowering Outcomes! 🧬 🔍 Embracing AI means faster timelines, diverse participant inclusion, and optimized resources. Plus, it's making clinical research more transparent and ethical than ever. 💡 With Jeeva's AI-powered platform, we're breaking barriers and fostering an inclusive and diverse participant pool. Join us as we reimagine the future of clinical trials! Learn more about it in PRWeb's news article: https://hubs.la/Q02pwbhp0 #JeevaClinicalTrials #ClinicalTrials #AI #HealthcareInnovation #InnovativeClinicalTrials #EfficientClinicalTrials #ClinicalTrialAutomation